[Antibody drug conjugates (ADC) and bispecific antibodies in oncology - report of the 2022 Saint Louis day].

Anticorps monoclonaux conjugués et bispécifiques en cancérologie – compte rendu de la Journée de Saint Louis 2022.
Humans Female Antibodies, Bispecific / therapeutic use Antineoplastic Agents / therapeutic use Breast Neoplasms / drug therapy Immunoconjugates / therapeutic use
Antibody drug conjugate Anticorps bispécifique Anticorps conjugué Bispecific antibody Pharmacocinétique Pharmacokinetics

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 23 03 2023
revised: 24 07 2023
accepted: 25 07 2023
medline: 1 12 2023
pubmed: 13 10 2023
entrez: 12 10 2023
Statut: ppublish

Résumé

Antibody Drug Conjugates (ADC) and bispecific antibodies are booming and were the subject of the scientific event proposed by the French Society of Oncological Pharmacy, October 13, 2022. An ADC is composed of the antibody targeting a receptor expressed on the tumor cell, the spacer making it possible to attach the cytotoxic to the antibody and to control its distribution in the body, and the cytotoxic. Therapeutic antibodies, monoclonal and conjugated, have particular pharmacokinetics. Unlike monoclonal antibodies for which the standard dose is most often fixed, this is expressed in mg/m

Identifiants

DOI: 10.1016/j.bulcan.2023.07.009 PMID: 37827964
pubmed: 37827964
pii: S0007-4551(23)00345-4
doi: 10.1016/j.bulcan.2023.07.009
pii:
doi:

Substances chimiques

glofitamab 06P3KLK2J8
Antibodies, Bispecific 0
Antineoplastic Agents 0
Immunoconjugates 0

Types de publication

Clinical Conference English Abstract

Langues

fre

Sous-ensembles de citation

IM

Pagination

1343-1351

Informations de copyright

Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Florence Ranchon (F)

Hospices civils de Lyon, groupement hospitalier Sud, unité de pharmacie clinique oncologique, Pierre-Bénite, France; Université Lyon 1, EA 3738, CICLY centre pour l'innovation en cancérologie de Lyon, 69921 Lyon, Oullins cedex, France; Société française de pharmacie oncologique (SFPO), Paris, France.

Étienne Chatelut (É)

Université Paul Sabatier, institut Claudius-Regaud, institut universitaire du cancer Toulouse - Oncopole ; CRCT, centre de recherche en cancérologie de Toulouse, Inserm U1037, Toulouse, France.

Juliette Lambert (J)

Centre hospitalier de Versailles, service d'hématologie, Le Chesnay, France.

Pierre Sesques (P)

Hospices civils de Lyon, groupement hospitalier Sud, unité d'hématologie clinique, Pierre-Bénite, France.

Constance Thibault (C)

AP-HP, hôpital européen Georges-Pompidou, institut du cancer Paris CARPEM, centre, service d'oncologie médicale, Paris, France.

Isabelle Madelaine (I)

AP-HP, hôpital Saint-Louis, pharmacie, Paris, France; Société française de pharmacie oncologique (SFPO), Paris, France.

Catherine Rioufol (C)

Hospices civils de Lyon, groupement hospitalier Sud, unité de pharmacie clinique oncologique, Pierre-Bénite, France; Université Lyon 1, EA 3738, CICLY centre pour l'innovation en cancérologie de Lyon, 69921 Lyon, Oullins cedex, France; Société française de pharmacie oncologique (SFPO), Paris, France.

Véronique Diéras (V)

Centre Eugène-Marquis, département d'oncologie médicale, Rennes, France.

Jean-Louis Cazin (JL)

UFR 3S (université de Lille), centre Oscar-Lambret, faculté de pharmacie, Lille, France; Société française de pharmacie oncologique (SFPO), Paris, France. Electronic address: j-cazin@o-lambret.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › [Antibody drug conjugates (ADC) and bispecific...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps bispécifiques › [Antibody drug conjugates (ADC) and bispecific...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › [Antibody drug conjugates (ADC) and bispecific...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › [Antibody drug conjugates (ADC) and bispecific...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Facteurs immunologiques › Immunoconjugués › [Antibody drug conjugates (ADC) and bispecific...